Haima Therapeutics

About:

Haima Therapeutics is a pre-clinical stage biotechnology company.

Website: http://www.haimatherapeutics.com/

Twitter/X: haimathr

Top Investors: National Science Foundation, National Institutes of Health, U.S. Department of Defense, MassChallenge

Description:

Haima Therapeutics is a pre-clinical stage biotechnology company. It focused on developing bio-inspired therapies for the treatment of bleeding and other blood-related ailments. It is developing platelet-inspired therapeutics to mitigate bleeding and treat other blood-related disorders where platelets play a key role in its progressions, such as thrombosis, inflammation, and cancer.